OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy
James L. Januzzi, Javed Butler, Stefano Del Prato, et al.
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 2, pp. 137-148
Closed Access | Times Cited: 8

Showing 8 citing articles:

Adenocarpine, Marmesin, and Lycocernuine from Ficus benjamina as Promising Inhibitors of Aldose Reductase in Diabetes: A Bioinformatics-Guided Approach
M. Oliur Rahman, Sheikh Sunzid Ahmed, Ali S. Alqahtani, et al.
Applied Biochemistry and Biotechnology (2025)
Closed Access

The Quest for Understanding Diabetic Cardiomyopathy
Anuradha Lala, Robert J. Mentz, Carlos G. Santos‐Gallego
Journal of the American College of Cardiology (2024) Vol. 84, Iss. 2, pp. 149-151
Closed Access | Times Cited: 3

Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference
Kartik Gupta, Bharat Rawlley, Chelsea Meloche, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 8, pp. 367-381
Closed Access | Times Cited: 2

Heartfelt Advances: ACC 2024 Clinical Trials Spotlight—New Horizons in Heart Failure Management
Jennifer Maning, Jonathan Hourmozdi, Sonu Abraham, et al.
Journal of Cardiac Failure (2024) Vol. 30, Iss. 7, pp. 943-946
Closed Access | Times Cited: 1

Relationship between NT-proBNP, echocardiographic abnormalities and functional status in patients with subclinical siabetic cardiomyopathy
Pishoy Gouda, Yuxi Liu, Javed Butler, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1

Development and validation of a machine learning‐based approach to identify high‐risk diabetic cardiomyopathy phenotype
Matthew W. Segar, Muhammad Usman, Kershaw V. Patel, et al.
European Journal of Heart Failure (2024)
Open Access | Times Cited: 1

News in cardiovascular pharmacotherapy from the ACC.24 Meeting
Ricardo Caballero, Eva Delpón, Juan Tamargo
European Heart Journal - Cardiovascular Pharmacotherapy (2024) Vol. 10, Iss. 4, pp. 272-277
Open Access

Selective aldose reductase inhibition as a treatment for diabetic cardiomyopathy: summary of the ARISE-HF trial
Laibah Arshad Khan, Muhammad Shahzeb Khan, Andrew P. Ambrosy, et al.
Heart Failure Reviews (2024) Vol. 29, Iss. 5, pp. 1157-1160
Closed Access

Page 1

Scroll to top